Skip to main content
SpringerLink
Log in

Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

To investigate whether functional polymorphisms exist in the C-reactive protein (CRP) gene, i.e., ones that contribute directly to differences in baseline CRP among individuals, we sequenced a 1,156-nucleotide-long stretch of the CRP gene promoter in 287 ostensibly healthy people. We identified two single-nucleotide polymorphisms (SNPs), a bi-allelic one at nucleotide −409 (G→A), and a tri-allelic one at −390 (C→T→A), both resident within the hexameric core of transcription factor binding E-box elements. Electrophoretic mobility shift assays confirmed that the SNP within the sequence −412CACGTG−407 (E-box 1) modulates transcription factor binding, and that the one within −394CACTTG−389 (E-box 2) supports transcription factor binding only when the −390 T allele is present. The commonest of four E-box 1/E-box 2 haplotypes (−409G/−390T) identified in the population supported highest promoter activity in luciferase reporter assays, and the rarest one (−409A/−390T) supported the least. Importantly, serum CRP in people with these haplotypes reproduced this rank order, i.e., people with the −409G/−390T haplotype had the highest baseline serum CRP (mean±SEM 10.9±2.25 μg/ml) and people with the −409A/−390T haplotype had the lowest (5.01±1.56 μg/ml). Furthermore, haplotype-associated differences in baseline CRP were not due to differences in age, sex, or race, and were still apparent in people with no history of smoking. At least two other SNPs in the CRP promoter lie within E-box elements (−198 C→T, E-box 4, and −861 T→C, E-box 3), indicating that not only is the quality of E-box sites in CRP a major determinant of baseline CRP level, but also that the number of E-boxes may be important. These data confirm that the CRP promoter does encode functional polymorphisms, which should be considered when baseline CRP is being used as an indicator of clinical outcome. Ultimately, development of genetic tests to screen for CRP expression variants could allow categorization of healthy people into groups at high versus low future risk of inflammatory disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kushner I (1982) The phenomenon of the acute phase response. Ann NY Acad Sci USA 389:39–48

    Google Scholar 

  2. Szalai AJ (2002) The biological functions of C-reactive protein. Vasc Pharmacol 39:105–107

    Google Scholar 

  3. Nauta AJ, Daha MR, van Kooten C, Roos A (2003) Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol 24:148–154

    Google Scholar 

  4. Danenberg HD, Szalai AJ, Swaminathan RV, Peng L, Chen Z, Seifert P, Fay WP, Simon DI, Edelman ER (2003) Increased arterial thrombosis following arterial injury in human C-reactive protein transgenic mice. Circulation 108:512–515

    Google Scholar 

  5. Paul A, Ko KWS, Li L, Yechoor V, McCrory MA, Szalai AJ, Chan L (2003) C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 109:647–655

    Google Scholar 

  6. Szalai AJ, Weaver CT, McCrory MA, van Ginkel FW, Reiman RM, Kearney JF, Marion TN, Volanakis JE (2003) Delayed lupus onset in (NZB × NZW)F1 mice expressing a human C-reactive protein transgene. Arthritis Rheum 48:1602–1611

    Google Scholar 

  7. Ballou SP, Kushner I (1992) C-reactive protein and the acute phase response. Adv Intern Med 37:313–336

    Google Scholar 

  8. Agrawal A, Cha-Molstad H, Samols D, Kushner I (2001) Transactivation of C-reactive protein by IL-6 requires synergistic interactions of CCAAT/enhancer binding protein β (C/EBPβ) and Rel p50. J Immunol 166:2378–2384

    Google Scholar 

  9. Agrawal A, Cha-Molstad H, Samols D, Kushner I (2003) Overexpressed nuclear factor κB can participate in endogenous C-reactive protein induction, and enhances the effect of C/EBPβ and signal transducer and activator of transcription-3. Immunology 108:539–547

    Google Scholar 

  10. Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, Lathrop M, Ratcliffe PJ, Watkins HC, Keavney B (2002) Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline plasma C-reactive protein. Cardiovasc Res 53:1029–1034

    Google Scholar 

  11. Berger P, McConnell JP, Nunn M, Kornman KS, Sorrell J, Stephenson K, Duff GW (2002) C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine 17:171–174

    Google Scholar 

  12. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation 107:499–511

    Article  PubMed  Google Scholar 

  13. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New Engl J Med 336:973–979

    Google Scholar 

  14. Koenig W (2003) Update on C-reactive protein as a risk marker in cardiovascular disease. Kidney Int 84:S58

    Google Scholar 

  15. Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH, Tracy RP (2001) Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atheriosclerosis 154:681–689

    Google Scholar 

  16. Zee RY, Ridker PM (2002) Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162:217–219

    Article  CAS  PubMed  Google Scholar 

  17. Szalai AJ, McCrory MA, Cooper GS, Wu J, Kimberly RP (2002) Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Gen Immun 3:14–19

    Google Scholar 

  18. Brull DJ, Serrano N, Zito F, Montgomery HE, Rumley A, Sharma P, Lowe GD, World MJ, Humphries SE, Hingorani AD (2003) Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23:2063–2069

    Article  CAS  PubMed  Google Scholar 

  19. Wu J, Metz C, Xu X, Abe R, Gibson AW, Edberg JC, Cooke J, Xie F, Cooper GS, Kimberly RP (2003) A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J Immunol 170:132–138

    Google Scholar 

  20. Szalai AJ, Briles DE, Volanakis JE (1995) Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol 155:2557–2563

    Google Scholar 

  21. Arcone R, Gualandi G, Ciliberto G (1998) Identification of sequences responsible for acute-phase induction of human C-reactive protein. Nucleic Acids Res 16:3195–3207

    Google Scholar 

  22. Murphy C, Beckers J, Rüther U (1995) Regulation of the human C-reactive protein gene in transgenic mice. J Biol Chem 270:704–708

    Google Scholar 

  23. Baudino TA, Cleveland JL (2001) The Max network gone Mad. Mol Cell Biol 21:691–702

    Article  CAS  PubMed  Google Scholar 

  24. Sirito M, Lin Q, Deng JM, Behringer RR, Sawadogo M (1998) Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice. Proc Natl Acad Sci USA 95:3758–3763

    Google Scholar 

  25. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397

    Article  CAS  PubMed  Google Scholar 

  26. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB (2000) Low grade inflammation and coronary heart disease: prospective study and up-dated meta-analyses. Br Med J 321:199–204

    Google Scholar 

  27. Wolford JK, Gruber JD, Ossowski VM, Vozarova B, Antonio Tataranni P, Bogardus C, Hanson RL (2003) A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metabol 78:136–144

    Article  Google Scholar 

  28. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O’Reilly DS, Packard CJ, Sattar N; West of Scotland Coronary Prevention Study (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the west of Scotland: coronary prevention study. Diabetes 51:1596–1600

    CAS  PubMed  Google Scholar 

  29. Cao H, Hegele RH (2000) Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet 45:100–101

    Article  CAS  PubMed  Google Scholar 

  30. Hegele RA, Ban MR, Young TK (2001) Serum C-reactive protein in Canadian Inuit and its association with genetic variation of 1q21. Clin Chem 47:1707–1709

    Google Scholar 

  31. Zito F, Hingorani A, Hawe E, Miller G, Humphries SE (2001) Identification of a novel (−748G>A) polymorphism in the promoter of the gene for CRP: lack of association with CRP levels in healthy men. BMC Meeting abstracts: 2nd Hot Topic Workshop on CRP. 1:50

  32. Russell AI, Cunninghame Graham DS, Shepherd C, Roberton CA, Whittaker J, Meeks J, Powell RJ, Isenberg DA, Walport MJ, Vyse TJ (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13:137–147

    Google Scholar 

  33. Chen J, Zhao J, Huang J, Su S, Qiang B, Gu D (2004) −717A>G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing atherosclerosis study. J Mol Med 83:72–78

    Google Scholar 

  34. Turner DM, Pravica V, Sinnott PJ, Hutchinson IV (2001) Polymorphism in the promoter region of the gene encoding human allograft inflammatory factor-1. Eur J Immunogenet 28:449–450

    Google Scholar 

  35. Mandola MV, Stoehlmacher J, Muller-Weeks S, Cesarone G, Yu MC, Lenz H-J, Ladner RD (2003) A novel single nucleotide polymorphism within the 5′ tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Res 63:2898–2904

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, 35294, USA

    A. J. Szalai, J. Wu, M. A. McCrory, F. Xie, Z. Fan, J. C. Edberg & R. P. Kimberly

  2. Department of Public Health Sciences, Wake Forest University, Winston-Salem, NC, 27157, USA

    E. M. Lange, C. D. Langefeld & A. Williams

  3. Section on Statistical Genetics, Department of Biostatistics, The University of Alabama at Birmingham, Birmingham, AL, 35294, USA

    S. O. Zakharkin, V. George & D. B. Allison

  4. Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC, 27709, USA

    G. S. Cooper

Authors
  1. A. J. Szalai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. M. Lange
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. A. McCrory
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. D. Langefeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. O. Zakharkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V. George
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. D. B. Allison
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. G. S. Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. F. Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Z. Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. J. C. Edberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. R. P. Kimberly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. J. Szalai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szalai, A.J., Wu, J., Lange, E.M. et al. Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med 83, 440–447 (2005). https://doi.org/10.1007/s00109-005-0658-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-005-0658-0

Keywords

Search

Navigation